Necrotizing Gingivostomatitis Treatment Market Size

  • Report ID: 3570
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Necrotizing Gingivostomatitis Treatment Market Size

Necrotizing Gingivostomatitis Treatment Market size was valued at USD 17.06 million in 2024 and is set to exceed USD 39.64 million by 2037, expanding at over 6.7% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of necrotizing gingivostomatitis treatment is evaluated at USD 18.94 million.

The growth of the market can be attributed to the increasing prevalence of gingivostomatitis in children across the world. The growing incidence of bacterial growth in the mouth owing to a lack of oral health habits is estimated to boost the market growth. Not brushing and flossing teeth on daily basis owing to a lack of awareness and education among illiterate people is expected to fuel the market growth in the coming years.  More than 70% of the American population brush their teeth only once a day as per the estimations in 2021.

The habit of oral sex with the infected person is also estimated to increase the risk of occurrence of gingivostomatitis in the people which thereby hike the market growth across the world. The growing use of antibiotics and over-the-counter (OTC) drugs for minor oral sores and injuries is also estimated to drive market growth. The market growth is also attributed to the increasing prevalence of HIV among adults owing to multiple sex partners or sex with an infected person. HIV makes the patient immunosuppressant leading to the incidence of more infections. According to the reports, the number of people in the U.S. living with HIV was estimated to be more than 1 million with over 33,000 new infections per annum during 2021.


Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3570
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of necrotizing gingivostomatitis treatment is evaluated at USD 18.94 million.

The necrotizing gingivostomatitis treatment market size was valued at USD 17.06 million in 2024 and is set to exceed USD 39.64 million by 2037, expanding at over 6.7% CAGR during the forecast period i.e., between 2025-2037. Increasing incidences of necrotizing gingivostomatitis and the rising use of public toilets will boost the market growth.

North America industry is expected to hold largest revenue share of 39% by 2037, attributed to high prevalence of lifestyle diseases, caused by inactive routines, busy lifestyles, and unhealthy eating habits.

The major players in the market are Novartis International AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sanofi S.A., GlaxoSmithKline plc, Merck & Co., Inc., Otsuka Pharmaceutical Co., Ltd., Abbott Laboratories, Eli Lilly and Company, Hindustan Antibiotics Limited, Aviro Health L.P.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample